0001079973-11-001021.txt : 20111222 0001079973-11-001021.hdr.sgml : 20111222 20111221203655 ACCESSION NUMBER: 0001079973-11-001021 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20111222 DATE AS OF CHANGE: 20111221 EFFECTIVENESS DATE: 20111222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-170543 FILM NUMBER: 111275650 BUSINESS ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 BUSINESS PHONE: 619-596-8600 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCE DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 D 1 primary_doc.xml X0704 D LIVE 0001006028 PURE BIOSCIENCE, INC. 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 619-596-8600 DELAWARE None PURE BIOSCIENCE PURE BIOSCIENCES INNOVATIVE MEDICAL SERVICES Corporation true 2011 Michael Krall 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 Executive Officer Director Craig Johnson 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 Executive Officer Donna Singer 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 Executive Officer Director Gregory Barnhill 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 Director Dennis Brovarone 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 Director John Carbone 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 Director Paul Maier 1725 GILLESPIE WAY EL CAJON CA CALIFORNIA 92020 Director Biotechnology Decline to Disclose 06 false 2011-12-14 true true false 0 Wharton Capital Markets LLC 44632 None None 25 KENSINGTON CIRCLE NORTH HILLS NY NEW YORK 11030 IL ILLINOIS false 7725000 225000 7500000 The total amount sold in Item 13(b) reflects the approximate value of commitment shares issued to one investor on December 14, 2011. See the issuer's Current Report on Form 8-K filed with the SEC on December 15, 2011. false 1 0 450000 true The issuer's payment of the amount reflected in this Item 15 is subject to the satisfaction of certain conditions. See the issuer's Current Report on Form 8-K filed with the SEC on December 15, 2011. 0 true false PURE BIOSCIENCE, INC. /s/ Craig Johnson Craig Johnson Chief Financial Officer 2011-12-21